Jack Geremia ^UDM

Jack Geremia, as CEO of Matterworks, spearheads a biotech startup that combines metabolomics with AI. Matterworks focuses on simulating the metabolic environment to accelerate therapeutic research and development. Geremia's leadership is crucial in advancing the company's AI-driven cloud platform for metabolomics and steering its strategic vision.